Baltazary Gasper, Akarro Rocky R J, Mussa A S
Department of Statistics, University of Dar es Salaam, P.O. Box 35047 Dar es Salaam, Tanzania.
East Afr J Public Health. 2011 Dec;8(4):237-46.
Tanzania is one of the nations that are highly affected by HIV/AIDS epidemic. Invention of ARVs (Anti -Retroviral) brought hope of extended life to people living with HIV/AIDS (PLHA). Though ARV's are administered in several clinics particularly in Dar es Salaam, there is a problem to adherence. Some factors associated with non-adherence are investigated and ways to optimize adherence are suggested.
This study was undertaken at three treatment and care clinics in Dar es Salaam. A sample of 197 individuals on ARV and 30 health care providers were interviewed. The sample comprised of 76 % females and 24% males, with mean age 34. About 74% of individuals on ARV were aged between 25 - 45 years. Logistic Regression and survival analysis models were used in the analysis.
Individuals on ARV recommended factors responsible for non-adherence as lack of awareness 63.5%, stigma 56%, side effects 53.3%, and costs 28%. Other factors were being busy 25.4%, away from home 21.3%, forgetting 12.2% and ARVs out of stock 10.2%. Proportion of PLHA lost to follow up was 26%. Awareness and side effects were found to be statistically significant, with p-values of 0.042 and 0.068 respectively (alpha = 0.1). The median survival time for individuals on ARV was 42 months (95% CI: 41-44) with survival rate of above 0.7. Log-rank test showed significant differences between the male and female on having a shorter time to death. Females seemed to survive longer than males suggesting that females adhere more to ART than males.
This calls for emphasis on HIV/AIDS education to the society especially to sensitize men. Another suggestion is that when a woman gets pregnant, both the expectant mother and father should attend maternal clinic so that they both take HIV test so as to increase man's participation.
坦桑尼亚是受艾滋病毒/艾滋病疫情影响严重的国家之一。抗逆转录病毒药物(ARVs)的发明给艾滋病毒/艾滋病感染者(PLHA)带来了延长生命的希望。尽管抗逆转录病毒药物在多个诊所尤其是达累斯萨拉姆的诊所中使用,但存在服药依从性的问题。本研究调查了一些与不依从相关的因素,并提出了优化依从性的方法。
本研究在达累斯萨拉姆的三个治疗与护理诊所进行。对197名服用抗逆转录病毒药物的个体和30名医疗服务提供者进行了访谈。样本中76%为女性,24%为男性,平均年龄34岁。服用抗逆转录病毒药物的个体中约74%年龄在25至45岁之间。分析中使用了逻辑回归和生存分析模型。
服用抗逆转录病毒药物的个体认为导致不依从的因素包括缺乏认识(63.5%)、耻辱感(56%)、副作用(53.3%)和费用(28%)。其他因素包括忙碌(25.4%)、离家在外(21.3%)、遗忘(12.2%)和抗逆转录病毒药物缺货(10.2%)。艾滋病毒/艾滋病感染者失访比例为26%。发现认识和副作用在统计学上具有显著性,p值分别为0.042和0.068(α = 0.1)。服用抗逆转录病毒药物个体的中位生存时间为42个月(95%置信区间:41 - 44),生存率高于0.7。对数秩检验显示男性和女性在死亡时间上存在显著差异。女性似乎比男性存活时间更长,这表明女性比男性更能坚持接受抗逆转录病毒治疗。
这需要加强对社会尤其是男性的艾滋病毒/艾滋病教育。另一个建议是,当女性怀孕时,准父母双方都应前往产科诊所,以便双方都进行艾滋病毒检测,从而提高男性的参与度。